Tag: avita

December 13, 2017

5 Top Pharmaceutical Stories of 2017

Here are the five top stories that caught the attention of our investor audience in the pharmaceutical business during 2017.
September 28, 2017

Avita Medical Announces FDA Submission of Premarket Approval Application

Avita Medical submitted a Pre-Market Approval application for its ReCell Autologous Cell Harvesting Device for treatment of burn injuries to...
March 23, 2017

Avita Talks Skin Regenerative Treatment

Avita Medical is taking the steps to expand its skin treatment technology and enter the US market.
March 3, 2017

Life Science Companies in the 2017 OTCQX Top 50

Living Cell Technologies and Avita Medical earned a spot in the top 50 companies of 2017 from OTCQX.
October 19, 2016

Avita Medical Announces Third Expansion of Compassionate Use Investigational Device Exemption for ReCell

Avita Medical announced that the US FDA has approved another increase in the number of patients who can be treated...
October 14, 2016

Avita Medical to Present at 2016 Dawson James Securities Growth Stock Conference

Avita Medical, a regenerative medicine company specializing in new treatments for wounds and skin defects, announced today that Timothy Rooney,...
October 5, 2016

FDA Approves Continued Access to ReCell(R) in US Burns Trial

The US Food and Drug Administration has approved Continued Access to ReCell, allowing US burns surgeons participating in Avita Medical's...